R
Rein Therapeutics Inc. (RNTX)
NCM – Real vaqt narxi. Valyuta: USD
0.97
+0.04 (3.83%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.96
-0.01 (-1.16%)
Bozordan keyin: Jun 26, 2026, 7:58 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.97
+0.04 (3.83%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.96
-0.01 (-1.16%)
Bozordan keyin: Jun 26, 2026, 7:58 PM EDT
Rein Therapeutics Inc. - bu AQShda kam uchraydigan o'pka va fibroz ko'rsatmalari bo'yicha qondirilmagan tibbiy ehtiyojlarni qondirish uchun dori vositalarini ishlab chiqishga qaratilgan biofarmatsevtika kompaniyasidir. Kompaniyaning yetakchi mahsulot nomzodi LTI-03 bo'lib, u idiopatik o'pka fibrozini (IPF) davolash uchun 2-bosqich klinik sinovdan o'tayotgan peptiddir. U, shuningdek, lokulatsiya qilingan plevral efüzyonni davolash uchun LPE bemorlarida 1b va 2a-bosqich klinik sinovlarini tugatgan proenzim LTI-01 ni taklif etadi. Kompaniyaning quvurlarida, shuningdek, kistik fibrozga qaratilgan preklinik dasturlar va tizimli fibroz ko'rsatmalari uchun kaveolin-1 oqsiliga qaratilgan peptid dasturi; va kistik fibrozni davolash uchun preklinik sinov bosqichida bo'lgan epitelial natriy kanal LTI-05 mavjud. Kompaniya ilgari Aileron Therapeutics, Inc. nomi bilan tanilgan va 2007 yil fevral oyida Rein Therapeutics Inc. nomini o'zgartirgan. Kompaniya 2001 yilda tashkil etilgan va shtab-kvartirasi Texasning Ostin shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Cory M. Hogaboam Ph.D. | Chief Scientific Officer |
| Mr. Ron Chen | VP of Finance and Corporate Controller |
| Ms. Jennifer Faigle | Counsel |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-08 | DEFA14A | rntx-defa14a-2026.htm |
| 2026-06-08 | DEF 14A | rntx-20260608.htm |
| 2026-06-08 | ARS | ars_-_2025_10-k.pdf |
| 2026-05-28 | PRE 14A | rntx-20260528.htm |
| 2026-05-15 | 10-Q | rntx-20260331.htm |
| 2026-05-04 | 8-K | d168655d8k.htm |
| 2026-04-28 | S-1 | d83075ds1.htm |
| 2026-04-28 | CORRESP | filename1.htm |
| 2026-04-27 | 10-K/A | rntx-20251231.htm |
| 2026-03-26 | 10-K | rntx-20251231.htm |